openPR Logo
Press release

Organoids Market is expected to reach US$ 3,420.40 million by 2027 With STEMCELL Technologies, Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Organoid Therapeutics, PeproTech, Thermo Fisher Scientific, Corning Incorporated (Life Science

05-07-2021 05:30 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
Organoids Market

Organoids Market

According to our new research study on “Organoids Market to 2027 – Global Analysis and Forecast – by Type, Application, and Source,” the organoids market was valued at US$ 689.47 million in 2019 and is projected to reach US$ 3,420.40 million by 2027; it is expected to grow at a CAGR of 22.1% during 2020–2027. The growth of the market is attributed to increasing demand for tumor modelling and biobanking, escalating adoption of personalized drugs, and growing focus on developing alternatives for animal testing models. However, issues related to the incorporation of organoids into existing workflows and dearth of skilled professionals hinder the growth of the market. `

Request Sample Copy of Organoids Market research report at – https://www.theinsightpartners.com/sample/TIPRE00017616/?openpr-10225

Company Profiles

STEMCELL Technologies, Inc.
Cellesce Ltd.
Hubrecht Organoid Technology
Definigen
3Dnamics, Inc.
Organoid Therapeutics
PeproTech, Inc.
Thermo Fisher Scientific
Corning Incorporated (Life Sciences)
Merck KGgA

In 2019, North America dominated the global organoids market. The market growth in the region is credited to the rise in the implementation of organoid-based research models in the biotechnology sector in US and Canada. These novel technologies have helped the researchers to overcome limitations faced by 2D cell culture platforms as 3D spheroids offer a microenvironment that can mimic the properties of human tissue structures. The market growth in Canada and Mexico is attributed to the presence of international market players, increasing adoption of advanced technologies, and existence of supportive government regulations. Based on type, the organoids market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and lung. The intestine segment accounted for more than 23.31% of the market in 2019. On the basis of application, the organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment is expected to held the largest share of the market in 2019 owing to its consideration as primary investigative research tool of the human developmental biology. Further, the pluripotent stem cells segment accounted for a larger share in the organoids market, by source, in 2019.

Increasing Use of Personalized Drugs Fuels Organoids Market Growth

Personalized medicine is a flourishing area of therapeutics that relies on specific drug delivery and dosing. As per a study published by PMC, personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005, whereas they accounted for more than 25% in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be prescribed as personalized medicines. Biopharmaceutical companies have nearly doubled their R&D investments in personalized drugs in the past five years, and they are further likely to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming five years.

The implementation of organoids to create personalized drug therapies is providing exciting opportunities for improving patient care. Recent research has highlighted that more than 50% of consumers express an interest in purchasing customized products or services. Since the release of the Precision Medicine Initiative in the US in 2015, pharmaceutical researchers have been pursuing the development of more tailored treatments for making medicines safer and more effective.

Personalized cancer therapy involves using personalized tumor models with similar characteristics to the original tumors, which may result in accurate predictions of drug responses in patients. One of the key advantages of tumor organoid models involve the conservation of molecular and cellular composition of the original tumor, which highlights the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.

Organoids Market: Segmental Overview

In terms of type, the kidney organoids segment is anticipated to register the highest CAGR in the organoids market during the forecast period. Kidney organoids, derived from human pluripotent stem cells, have the potential to assist the drug development process. An international team of researchers—led by Nanyang Technological University Singapore (NTU Singapore)—has grown “miniature kidneys” in laboratory, which could be used to better understand the mechanism of development of renal diseases in individual patients. The mini kidneys, i.e., kidney organoids, were grown in vitro from skin cells derived from a single patient who had polycystic kidney disease, one of the most common inherited causes of kidney failure in adults. In terms of application, the developmental biology disease segment accounted for more than 29% share in global organoids market in 2019. In terms of source, the market for the pluripotent stem cells segment is anticipated to grow at a higher CAGR during the forecast period.

Organoids Market: Competition Landscape and Key Developments

STEMCELL Technologies, Inc, Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Inc., Organoid Therapeutics, PeproTech, Inc., Thermo Fisher Scientific, Corning Incorporated (Life Sciences) and Merck KGgA. are among the key companies operating in the global organoids market. Leading players are focusing on the expansion and diversification of their market presence, and acquisition of new customer base, thereby tapping prevailing business opportunities.

In October 2019, Corning Incorporated launched two new products—Elplasia and Matrigel—to its organoid culture portfolio to provide new solutions to support spheroid and organoid culture models. Elplasia, a 3D cell culture microplate, features a microcavity technology that enables high-volume spheroid formation, culture, and analysis. The Matrigel matrix for organoid culture is optimized to support organoid growth and differentiation.

In Sep-2018, STEMCELL Technologies Signed a partnership agreement with Brigham and Women’s Hospital to commercialize a human pluripotent stem cell-derived kidney organoid culture system.

Market Segmentation

By Type

Stomach
Intestine
Liver
Pancreas
Lung
Brain
Kidney
Others

By Application

Developmental Biology
Disease Pathology of Infectious Disease
Regenerative Medicine
Drug Toxicity and Efficacy Testing
Drug Discovery and Personalized Medicine
Others

By Source

Pluripotent Stem Cells
Organ-Specific Adult Stem Cells

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
UK
Italy
Spain
Rest of Europe
Asia Pacific (APAC)
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Middle East & Africa (MEA)
Saudi Arabia
South Africa
UAE
Rest of Middle East & Africa
South America (SCAM)
Brazil
Argentina
Rest of South & Central America

Order a copy of this research Organoids Market research report at – https://www.theinsightpartners.com/buy/TIPRE00017616/?openpr-10225

Contact US:
If you have any queries about this report or would like further information, please contact us:
North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686
Email: sales@theinsightpartners.com

ABOUT US:
The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.
Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Organoids Market is expected to reach US$ 3,420.40 million by 2027 With STEMCELL Technologies, Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Organoid Therapeutics, PeproTech, Thermo Fisher Scientific, Corning Incorporated (Life Science here

News-ID: 2281753 • Views:

More Releases from The Insight Partners

Theobroma Oil Market Outlook to 2031: Trends and Future Opportunities
Theobroma Oil Market Outlook to 2031: Trends and Future Opportunities
The global Theobroma Oil Market is projected to grow at a CAGR of 5.6% between 2025 and 2031, entering a crucial phase of expansion. Widely recognized as cocoa butter, Theobroma oil is valued for its natural composition, versatility, and broad range of applications. Its demand is steadily increasing across the food, personal care, and pharmaceutical industries. From enhancing the taste and texture of chocolates to serving as a key ingredient
Rising Demand in Diagnostics and Life Sciences Fuels Growth in the Cell Counting Market
Rising Demand in Diagnostics and Life Sciences Fuels Growth in the Cell Counting …
The Insight Partners is pleased to announce the release of its latest in-depth market intelligence: "Cell Counting Market: An In-depth Analysis of the Cell Counting Market." This comprehensive study provides a 360° view of the current landscape, future trends, competitive dynamics, and growth projections in the cell counting industry. Check valuable insights in the Cell Counting report. You can easily get a sample PDF of the report - https://www.theinsightpartners.com/sample/TIPHE100001250?utm_source=OpenPr&utm_medium=10457 Overview of the
Solar and Wind Renewable Energy Market Global Industry Analysis, Size, Investment Analysis, Trends, Growth, Development Factors, Future Scope, Challenges and 2031 Forecast Research Report
Solar and Wind Renewable Energy Market Global Industry Analysis, Size, Investmen …
Global Solar and Wind Renewable Energy Market Report is a professional and in-depth survey on the current state of the Cervical Pillows Industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Solar and Wind Renewable Energy Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003246?utm_source=OpenPR&utm_medium=10881 Key Players
Top Carbon Fiber Companies Regional and Data Analysis to 2031
Top Carbon Fiber Companies Regional and Data Analysis to 2031
Carbon fiber is a composite material composed of thin, strong crystalline filaments of carbon. It combines exceptional strength-to-weight ratio, high stiffness, and thermal resistance, making it stronger than steel yet much lighter. Due to these properties, it is widely used in aerospace, automotive, defense, sports equipment, and industrial applications. Its durability, corrosion resistance, and sleek finish also add to its appeal in advanced engineering and design. Download Sample PDF Copy https://www.theinsightpartners.com/sample/TIPRE00002830/?utm_source=OpenPR&utm_medium=10826 The

All 5 Releases


More Releases for Organoid

07-17-2025 | Health & Medicine
4Dcell
4Dcell Achieves 95% Organoid Reproducibility Breakthrough With Patented Anchorin …
4Dcell announced that its SmartSphero plates have achieved over 95% reproducibility in organoid size and shape, while reducing organoid loss during medium exchanges to below 12%, a significant improvement over the 86% loss seen in traditional unanchored systems. This breakthrough addresses a persistent challenge in pharmaceutical drug screening and safety testing, where inconsistent organoid cultures have often hindered data reliability. The company's patented Anchoring Point Technology (APT®) allows researchers to culture
Organoid Culture Medium Research:the global Organoid Culture Medium market size …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Organoid Culture Medium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.
Organoid Technology Market Size, Growth, In-depth Analysis, Research Report Fore …
The organoid technology market is estimated to grow at a CAGR of 27.12% during the forecast period. The prime factors propelling the growth of the organoid technology market are increasing demand for personalized medicine, drug discovery and development, and regenerative medicine. As per the report, the organoid technology market is expected to grow rapidly during the forecast period. Organoids are three-dimensional cell cultures that mimic the structure and function of human organs, making
Organoid Technology Market Trends, Future Demands, Growth Factors, Emerging Tech …
The global Organoids and Spheroids Market size was valued at $516.6 million in 2021 and is projected to reach $1.2 billion by 2031, growing at a CAGR of 8.5% from 2022 to 2031. Organoid technology bridges the gap between conventional two-dimensional cell line culture and in vivo models. The near-physiological technology can virtually recapitulates organ development and human diseases, such as infectious diseases, genetic abnormality and even cancers. Between traditional two-dimensional cell
Organoids Market Driven By Definigen, Organoid Therapeutics, Hubrecht Organoid T …
The scope of the organoids market includes type, application, source, and region. The organoids market is analyzed based on regions, such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the organoids market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.
Organoids Market Witness Heightened Revenue of US$ 3,420.40 million by 2027 with …
The Organoids Market was valued at US$ 689.47 million in 2019 and it is projected to reach US$ 3,420.40 million by 2027; it is expected to grow at a CAGR of 22.1% from 2020 to 2027. Organoids are tiny, self-organized three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ, or to express selected aspects of it like